Denmark· DK-28105850516

Symtuza

A emtricitabine, tenofovir alafenamide, darunavir and cobicistat product containing cobicistat, darunavirethanolat, emtricitabin, tenofovir alafenamid fumarat, registered in Denmark by Janssen-Cilag International NV. The same ATC class is registered in 12 of our 19 countries.

ATC J05AR22

Checked against Danish Medicines Agency (Denmark) on

Informational only — not a medical device.

SOURCE REGISTER · DKDanish Medicines Agency (Denmark)normalisedSymtuzaATCJ05AR22REGISTER NO.DK-28105850516PACKS LISTED1CHECKEDSeptember 30, 2026

Where it is registered

Emtricitabine, tenofovir alafenamide, darunavir and cobicistat is registered in 12 of 19 countries.

Countries holding a registration under ATC J05AR22 (emtricitabine, tenofovir alafenamide, darunavir and cobicistat), each read from that country’s own register.

  • This record: Denmark, from Danish Medicines Agency (Denmark)
  • 8 of them publish a price we can compare per daily dose

Emtricitabine, tenofovir alafenamide, darunavir and cobicistat · ATC J05AR22

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Danish Medicines Agency (Denmark)
Active substance
Cobicistat, Darunavirethanolat, EMTRICITABIN, Tenofovir alafenamid fumarat
Manufacturer
Janssen-Cilag International NV
Country
Denmark (DK)
ATC code
J05AR22
ATC class
Emtricitabine, tenofovir alafenamide, darunavir and cobicistat
Reimbursed
Not published by this register
Source register
Danish Medicines Agency (Denmark)
Last checked
September 30, 2026

Packs & prices · 1

  • dk_varenummer
    28105850516

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/33d42fa0-6968-4d77-b752-19728e68a7e3
GET /v1/drugs/33d42fa0-6968-4d77-b752-19728e68a7e3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "filmovertrukne tabletter",
  "source": "dkma",
  "strength": "800+150+200+10 mg",
  "auth_role": "MOD",
  "dk_drugid": "28105850516",
  "substance": "Cobicistat, Darunavirethanolat, EMTRICITABIN, Tenofovir alafenamid fumarat",
  "auth_procedure": "Central",
  "in_medicinpriser": true,
  "registration_date_serial": "43003"
}

See everything about emtricitabine, tenofovir alafenamide, darunavir and cobicistat.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.